We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+7.8%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$484B
AUM Growth
+$29.1B
Cap. Flow
-$16.6B
Cap. Flow %
-3.43%
Top 10 Hldgs %
36.47%
Holding
15,826
New
1,205
Increased
5,575
Reduced
7,223
Closed
1,562

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$545M
2
DXCM icon
DexCom
DXCM
+$457M
3
T icon
AT&T
T
+$431M
4
PANW icon
Palo Alto Networks
PANW
+$416M
5
HUM icon
Humana
HUM
+$394M

Sector Composition

Rank Sector Weight
1 Technology 3.03%
2 Healthcare 2.92%
3 Consumer Discretionary 1.99%
4 Financials 1.93%
5 Industrials 1.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
THMO
12801
DELISTED
ThermoGenesis Holdings, Inc. Common Stock
THMO
$16.8K ﹤0.01%
+13,421
New +$23.4K
CAPR icon
12802
PUT
Capricor Therapeutics
CAPR
$386M
$16.7K ﹤0.01%
3,500
-41,300
-92% -$181K
CGRN
12803
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$16.7K ﹤0.01%
13,931
+510
+4% +$624
INZY
12804
CALL
DELISTED
Inozyme Pharma
INZY
$16.7K ﹤0.01%
3,000
-3,300
-52% -$19.5K
ARVL
12805
CALL
DELISTED
Arrival Ordinary Shares
ARVL
$16.7K ﹤0.01%
6,470
-108
-2% -$342
OFG icon
12806
OFG Bancorp
OFG
$2.28B
$16.7K ﹤0.01%
640
-20,848
-97% -$523K
AUTL
12807
PUT
Autolus Therapeutics
AUTL
$572M
$16.7K ﹤0.01%
7,000
-300
-4% -$712
NUVA
12808
PUT
DELISTED
NuVasive, Inc.
NUVA
$16.6K ﹤0.01%
+400
New +$16.4K
CEPU
12809
PUT
Central Puerto
CEPU
$1.97B
$16.6K ﹤0.01%
2,400
+900
+60% +$5.75K
VMD icon
12810
PUT
Viemed Healthcare
VMD
$350M
$16.6K ﹤0.01%
1,700
+700
+70% +$7.11K
JANX icon
12811
PUT
Janux Therapeutics
JANX
$986M
$16.6K ﹤0.01%
1,400
-700
-33% -$9.36K
CCLP
12812
CALL
DELISTED
CSI Compressco LP
CCLP
$16.6K ﹤0.01%
13,600
+12,900
+1,843% +$15.1K
SPHD icon
12813
PUT
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.44B
$16.5K ﹤0.01%
400
-5,900
-94% -$243K
VNET
12814
CALL
VNET Group
VNET
$2.16B
$16.5K ﹤0.01%
+5,700
New +$17.3K
BCAB icon
12815
PUT
BioAtla
BCAB
$5.15M
$16.5K ﹤0.01%
110
-86
-44% -$14.8K
CMCT
12816
PUT
Creative Media & Community Trust
CMCT
$14M
0
THM
12817
International Tower Hill Mines
THM
$712M
$16.4K ﹤0.01%
39,226
+23,007
+142% +$11.6K
USIO icon
12818
CALL
Usio Inc
USIO
$78.6M
$16.4K ﹤0.01%
8,800
-15,100
-63% -$29.3K
PRF icon
12819
CALL
Invesco FTSE RAFI US 1000 ETF
PRF
$10.1B
$16.4K ﹤0.01%
500
-500
-50% -$15.8K
NVNO
12820
CALL
enVVeno Medical
NVNO
$7.5M
$16.3K ﹤0.01%
+151
New +$19.6K
LOMA
12821
CALL
Loma Negra
LOMA
$1.1B
$16.3K ﹤0.01%
2,400
-13,800
-85% -$89.8K
CALF icon
12822
PUT
Pacer US Small Cap Cash Cows 100 ETF
CALF
$3.89B
$16.3K ﹤0.01%
+400
New +$15.2K
LDI icon
12823
loanDepot
LDI
$303M
$16.3K ﹤0.01%
7,671
+7,572
+7,648% +$13.9K
ONEQ icon
12824
PUT
Fidelity Nasdaq Composite Index ETF
ONEQ
$10.9B
$16.2K ﹤0.01%
300
-4,400
-94% -$219K
KRNY icon
12825
CALL
Kearny Financial
KRNY
$605M
$16.2K ﹤0.01%
2,300
+1,600
+229% +$11.9K

Similar funds

Ken Griffin's Q2 2023 Portfolio in Review

As of Q2 2023, Ken Griffin held 15,826 positions worth $484B, up 6.4% from $455B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Ken Griffin withdrew a net $16.6B in Q2 2023, closing 1,562 positions and reducing 7,223 holdings. Its most notable exit was State Street Industrial Select Sector SPDR ETF, an estimated $192M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.2% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Ken Griffin opened a new position in BILL Holdings worth $222M.

  • Ken Griffin's largest Q2 2023 buy was BILL Holdings: 1,901,064 shares worth $222M.
  • Ken Griffin added most to Microsoft in Q2 2023, an estimated $640M increase.
  • Ken Griffin's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $545M.
  • Ken Griffin fully exited State Street Industrial Select Sector SPDR ETF in Q2 2023, selling an estimated $192M.
  • Ken Griffin's ten largest holdings make up 36% of its $484B portfolio in Q2 2023.
  • Ken Griffin opened 1,205 new positions and closed 1,562 in Q2 2023.
  • Ken Griffin's portfolio value rose 6.4% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.